Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 150 participants.

Also called NCT03635424

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 150 participants (enrolled count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as the lead sponsor
Registry
  • NCT NCT03635424
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(anticipated) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT03635424. Allocation not applicable; no masking; primary purpose treatment. Start 2018-10-30 (actual); primary completion 2019-11-13 (actual). Results posted on 2020-12-21.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Medtronic Transcatheter Aortic Valve Replacement (TAVR) Low Risk Bicuspid Study
Condition
Bicuspid Aortic Valve
Intervention (Device)
Medtronic TAVR Systems
Lead sponsor
Medtronic Cardiovascular (class: industry)

Record details

Record id
cardio:ct-nct03635424
Content hash
a90b861efb4463bf4714b3d91412f9e29730d9487fa35a855385fd0a60bec2ed